Efficacy of Tegoprazan in Patients with Laryngopharyngeal Reflux Disease: A Preliminary Feasibility Study

Tegoprazan is a novel, potent, and highly selective potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset of action and prolonged control of gastric acidity. We performed a preliminary feasibility study to evaluate whether tegoprazan could control symptoms more eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hye Kyung, Kim, Gwang Ha, Cheon, Yong-Il, Shin, Sung-Chan, Lee, Byung Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573336/
https://www.ncbi.nlm.nih.gov/pubmed/37834761
http://dx.doi.org/10.3390/jcm12196116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573336/
https://www.ncbi.nlm.nih.gov/pubmed/37834761
http://dx.doi.org/10.3390/jcm12196116

Ejemplares similares